This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08211/identifier/pdb/
n12http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08211/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08211/identifier/pubchem-substance/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08211/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08211/identifier/chemspider/

Statements

Subject Item
n2:DB08211
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB08211 n13:DB08211
dcterms:title
5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide
adms:identifier
n6:MRX n7:11984575 n8:10157075 n9:DB08211 n14:99444682
n3:IUPAC-Name
n4:271B421F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4225-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4224-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4221-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4222-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4223-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B421D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B421B-363D-11E5-9242-09173F13E4C5 n4:271B421E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B421C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B422B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B422C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4226-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4227-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4229-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4228-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B422A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4231-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4233-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4234-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4230-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B422F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4232-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4220-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B422D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B422E-363D-11E5-9242-09173F13E4C5